Genetic Obesity Drug Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Drug Type
1.2.1 Global Genetic Obesity Drug Market Size Growth Rate by Drug Type: 2017 VS 2021 VS 2028
1.2.2 Sibutramine
1.2.3 Orlistat
1.2.4 Sympathomimetic Drugs
1.2.5 Receptors Antagonists
1.2.6 Others
1.3 Market by Application
1.3.1 Global Genetic Obesity Drug Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Genetic Obesity Drug Market Perspective (2017-2028)
2.2 Genetic Obesity Drug Growth Trends by Region
2.2.1 Genetic Obesity Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Genetic Obesity Drug Historic Market Size by Region (2017-2022)
2.2.3 Genetic Obesity Drug Forecasted Market Size by Region (2023-2028)
2.3 Genetic Obesity Drug Market Dynamics
2.3.1 Genetic Obesity Drug Industry Trends
2.3.2 Genetic Obesity Drug Market Drivers
2.3.3 Genetic Obesity Drug Market Challenges
2.3.4 Genetic Obesity Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genetic Obesity Drug Players by Revenue
3.1.1 Global Top Genetic Obesity Drug Players by Revenue (2017-2022)
3.1.2 Global Genetic Obesity Drug Revenue Market Share by Players (2017-2022)
3.2 Global Genetic Obesity Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genetic Obesity Drug Revenue
3.4 Global Genetic Obesity Drug Market Concentration Ratio
3.4.1 Global Genetic Obesity Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genetic Obesity Drug Revenue in 2021
3.5 Genetic Obesity Drug Key Players Head office and Area Served
3.6 Key Players Genetic Obesity Drug Product Solution and Service
3.7 Date of Enter into Genetic Obesity Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genetic Obesity Drug Breakdown Data by Drug Type
4.1 Global Genetic Obesity Drug Historic Market Size by Drug Type (2017-2022)
4.2 Global Genetic Obesity Drug Forecasted Market Size by Drug Type (2023-2028)
5 Genetic Obesity Drug Breakdown Data by Application
5.1 Global Genetic Obesity Drug Historic Market Size by Application (2017-2022)
5.2 Global Genetic Obesity Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Genetic Obesity Drug Market Size (2017-2028)
6.2 North America Genetic Obesity Drug Market Size by Country (2017-2022)
6.3 North America Genetic Obesity Drug Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Genetic Obesity Drug Market Size (2017-2028)
7.2 Europe Genetic Obesity Drug Market Size by Country (2017-2022)
7.3 Europe Genetic Obesity Drug Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genetic Obesity Drug Market Size (2017-2028)
8.2 Asia-Pacific Genetic Obesity Drug Market Size by Country (2017-2022)
8.3 Asia-Pacific Genetic Obesity Drug Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Genetic Obesity Drug Market Size (2017-2028)
9.2 Latin America Genetic Obesity Drug Market Size by Country (2017-2022)
9.3 Latin America Genetic Obesity Drug Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genetic Obesity Drug Market Size (2017-2028)
10.2 Middle East & Africa Genetic Obesity Drug Market Size by Country (2017-2022)
10.3 Middle East & Africa Genetic Obesity Drug Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Pfizer, Inc.
11.1.1 Pfizer, Inc. Company Detail
11.1.2 Pfizer, Inc. Business Overview
11.1.3 Pfizer, Inc. Genetic Obesity Drug Introduction
11.1.4 Pfizer, Inc. Revenue in Genetic Obesity Drug Business (2017-2022)
11.1.5 Pfizer, Inc. Recent Development
11.2 Sanofi.
11.2.1 Sanofi. Company Detail
11.2.2 Sanofi. Business Overview
11.2.3 Sanofi. Genetic Obesity Drug Introduction
11.2.4 Sanofi. Revenue in Genetic Obesity Drug Business (2017-2022)
11.2.5 Sanofi. Recent Development
11.3 Tonghua Dongbao Pharmaceutical Co., Ltd.
11.3.1 Tonghua Dongbao Pharmaceutical Co., Ltd. Company Detail
11.3.2 Tonghua Dongbao Pharmaceutical Co., Ltd. Business Overview
11.3.3 Tonghua Dongbao Pharmaceutical Co., Ltd. Genetic Obesity Drug Introduction
11.3.4 Tonghua Dongbao Pharmaceutical Co., Ltd. Revenue in Genetic Obesity Drug Business (2017-2022)
11.3.5 Tonghua Dongbao Pharmaceutical Co., Ltd. Recent Development
11.4 Biocon.
11.4.1 Biocon. Company Detail
11.4.2 Biocon. Business Overview
11.4.3 Biocon. Genetic Obesity Drug Introduction
11.4.4 Biocon. Revenue in Genetic Obesity Drug Business (2017-2022)
11.4.5 Biocon. Recent Development
11.5 Adocia
11.5.1 Adocia Company Detail
11.5.2 Adocia Business Overview
11.5.3 Adocia Genetic Obesity Drug Introduction
11.5.4 Adocia Revenue in Genetic Obesity Drug Business (2017-2022)
11.5.5 Adocia Recent Development
11.6 GlaxoSmithKline Plc.
11.6.1 GlaxoSmithKline Plc. Company Detail
11.6.2 GlaxoSmithKline Plc. Business Overview
11.6.3 GlaxoSmithKline Plc. Genetic Obesity Drug Introduction
11.6.4 GlaxoSmithKline Plc. Revenue in Genetic Obesity Drug Business (2017-2022)
11.6.5 GlaxoSmithKline Plc. Recent Development
11.7 Novo Nordisk A/S.
11.7.1 Novo Nordisk A/S. Company Detail
11.7.2 Novo Nordisk A/S. Business Overview
11.7.3 Novo Nordisk A/S. Genetic Obesity Drug Introduction
11.7.4 Novo Nordisk A/S. Revenue in Genetic Obesity Drug Business (2017-2022)
11.7.5 Novo Nordisk A/S. Recent Development
11.8 Oramed Pharmaceuticals, Inc
11.8.1 Oramed Pharmaceuticals, Inc Company Detail
11.8.2 Oramed Pharmaceuticals, Inc Business Overview
11.8.3 Oramed Pharmaceuticals, Inc Genetic Obesity Drug Introduction
11.8.4 Oramed Pharmaceuticals, Inc Revenue in Genetic Obesity Drug Business (2017-2022)
11.8.5 Oramed Pharmaceuticals, Inc Recent Development
11.9 Wockhardt.
11.9.1 Wockhardt. Company Detail
11.9.2 Wockhardt. Business Overview
11.9.3 Wockhardt. Genetic Obesity Drug Introduction
11.9.4 Wockhardt. Revenue in Genetic Obesity Drug Business (2017-2022)
11.9.5 Wockhardt. Recent Development
11.10 Eli Lilly and Company.
11.10.1 Eli Lilly and Company. Company Detail
11.10.2 Eli Lilly and Company. Business Overview
11.10.3 Eli Lilly and Company. Genetic Obesity Drug Introduction
11.10.4 Eli Lilly and Company. Revenue in Genetic Obesity Drug Business (2017-2022)
11.10.5 Eli Lilly and Company. Recent Development
11.11 Merck & Co., Inc.
11.11.1 Merck & Co., Inc. Company Detail
11.11.2 Merck & Co., Inc. Business Overview
11.11.3 Merck & Co., Inc. Genetic Obesity Drug Introduction
11.11.4 Merck & Co., Inc. Revenue in Genetic Obesity Drug Business (2017-2022)
11.11.5 Merck & Co., Inc. Recent Development
11.12 Julphar.
11.12.1 Julphar. Company Detail
11.12.2 Julphar. Business Overview
11.12.3 Julphar. Genetic Obesity Drug Introduction
11.12.4 Julphar. Revenue in Genetic Obesity Drug Business (2017-2022)
11.12.5 Julphar. Recent Development
11.13 Bristol-Myers Squibb Company.
11.13.1 Bristol-Myers Squibb Company. Company Detail
11.13.2 Bristol-Myers Squibb Company. Business Overview
11.13.3 Bristol-Myers Squibb Company. Genetic Obesity Drug Introduction
11.13.4 Bristol-Myers Squibb Company. Revenue in Genetic Obesity Drug Business (2017-2022)
11.13.5 Bristol-Myers Squibb Company. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Genetic Obesity Drug Market Size Growth Rate by Drug Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Sibutramine
Table 3. Key Players of Orlistat
Table 4. Key Players of Sympathomimetic Drugs
Table 5. Key Players of Receptors Antagonists
Table 6. Key Players of Others
Table 7. Global Genetic Obesity Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Genetic Obesity Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Genetic Obesity Drug Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Genetic Obesity Drug Market Share by Region (2017-2022)
Table 11. Global Genetic Obesity Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Genetic Obesity Drug Market Share by Region (2023-2028)
Table 13. Genetic Obesity Drug Market Trends
Table 14. Genetic Obesity Drug Market Drivers
Table 15. Genetic Obesity Drug Market Challenges
Table 16. Genetic Obesity Drug Market Restraints
Table 17. Global Genetic Obesity Drug Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Genetic Obesity Drug Market Share by Players (2017-2022)
Table 19. Global Top Genetic Obesity Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Obesity Drug as of 2021)
Table 20. Ranking of Global Top Genetic Obesity Drug Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Genetic Obesity Drug Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Genetic Obesity Drug Product Solution and Service
Table 24. Date of Enter into Genetic Obesity Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Genetic Obesity Drug Market Size by Drug Type (2017-2022) & (US$ Million)
Table 27. Global Genetic Obesity Drug Revenue Market Share by Drug Type (2017-2022)
Table 28. Global Genetic Obesity Drug Forecasted Market Size by Drug Type (2023-2028) & (US$ Million)
Table 29. Global Genetic Obesity Drug Revenue Market Share by Drug Type (2023-2028)
Table 30. Global Genetic Obesity Drug Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Genetic Obesity Drug Revenue Market Share by Application (2017-2022)
Table 32. Global Genetic Obesity Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Genetic Obesity Drug Revenue Market Share by Application (2023-2028)
Table 34. North America Genetic Obesity Drug Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Genetic Obesity Drug Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Genetic Obesity Drug Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Genetic Obesity Drug Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Genetic Obesity Drug Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Genetic Obesity Drug Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Genetic Obesity Drug Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Genetic Obesity Drug Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Genetic Obesity Drug Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Genetic Obesity Drug Market Size by Country (2023-2028) & (US$ Million)
Table 44. Pfizer, Inc. Company Detail
Table 45. Pfizer, Inc. Business Overview
Table 46. Pfizer, Inc. Genetic Obesity Drug Product
Table 47. Pfizer, Inc. Revenue in Genetic Obesity Drug Business (2017-2022) & (US$ Million)
Table 48. Pfizer, Inc. Recent Development
Table 49. Sanofi. Company Detail
Table 50. Sanofi. Business Overview
Table 51. Sanofi. Genetic Obesity Drug Product
Table 52. Sanofi. Revenue in Genetic Obesity Drug Business (2017-2022) & (US$ Million)
Table 53. Sanofi. Recent Development
Table 54. Tonghua Dongbao Pharmaceutical Co., Ltd. Company Detail
Table 55. Tonghua Dongbao Pharmaceutical Co., Ltd. Business Overview
Table 56. Tonghua Dongbao Pharmaceutical Co., Ltd. Genetic Obesity Drug Product
Table 57. Tonghua Dongbao Pharmaceutical Co., Ltd. Revenue in Genetic Obesity Drug Business (2017-2022) & (US$ Million)
Table 58. Tonghua Dongbao Pharmaceutical Co., Ltd. Recent Development
Table 59. Biocon. Company Detail
Table 60. Biocon. Business Overview
Table 61. Biocon. Genetic Obesity Drug Product
Table 62. Biocon. Revenue in Genetic Obesity Drug Business (2017-2022) & (US$ Million)
Table 63. Biocon. Recent Development
Table 64. Adocia Company Detail
Table 65. Adocia Business Overview
Table 66. Adocia Genetic Obesity Drug Product
Table 67. Adocia Revenue in Genetic Obesity Drug Business (2017-2022) & (US$ Million)
Table 68. Adocia Recent Development
Table 69. GlaxoSmithKline Plc. Company Detail
Table 70. GlaxoSmithKline Plc. Business Overview
Table 71. GlaxoSmithKline Plc. Genetic Obesity Drug Product
Table 72. GlaxoSmithKline Plc. Revenue in Genetic Obesity Drug Business (2017-2022) & (US$ Million)
Table 73. GlaxoSmithKline Plc. Recent Development
Table 74. Novo Nordisk A/S. Company Detail
Table 75. Novo Nordisk A/S. Business Overview
Table 76. Novo Nordisk A/S. Genetic Obesity Drug Product
Table 77. Novo Nordisk A/S. Revenue in Genetic Obesity Drug Business (2017-2022) & (US$ Million)
Table 78. Novo Nordisk A/S. Recent Development
Table 79. Oramed Pharmaceuticals, Inc Company Detail
Table 80. Oramed Pharmaceuticals, Inc Business Overview
Table 81. Oramed Pharmaceuticals, Inc Genetic Obesity Drug Product
Table 82. Oramed Pharmaceuticals, Inc Revenue in Genetic Obesity Drug Business (2017-2022) & (US$ Million)
Table 83. Oramed Pharmaceuticals, Inc Recent Development
Table 84. Wockhardt. Company Detail
Table 85. Wockhardt. Business Overview
Table 86. Wockhardt. Genetic Obesity Drug Product
Table 87. Wockhardt. Revenue in Genetic Obesity Drug Business (2017-2022) & (US$ Million)
Table 88. Wockhardt. Recent Development
Table 89. Eli Lilly and Company. Company Detail
Table 90. Eli Lilly and Company. Business Overview
Table 91. Eli Lilly and Company. Genetic Obesity Drug Product
Table 92. Eli Lilly and Company. Revenue in Genetic Obesity Drug Business (2017-2022) & (US$ Million)
Table 93. Eli Lilly and Company. Recent Development
Table 94. Merck & Co., Inc. Company Detail
Table 95. Merck & Co., Inc. Business Overview
Table 96. Merck & Co., Inc. Genetic Obesity DrugProduct
Table 97. Merck & Co., Inc. Revenue in Genetic Obesity Drug Business (2017-2022) & (US$ Million)
Table 98. Merck & Co., Inc. Recent Development
Table 99. Julphar. Company Detail
Table 100. Julphar. Business Overview
Table 101. Julphar. Genetic Obesity DrugProduct
Table 102. Julphar. Revenue in Genetic Obesity Drug Business (2017-2022) & (US$ Million)
Table 103. Julphar. Recent Development
Table 104. Bristol-Myers Squibb Company. Company Detail
Table 105. Bristol-Myers Squibb Company. Business Overview
Table 106. Bristol-Myers Squibb Company. Genetic Obesity DrugProduct
Table 107. Bristol-Myers Squibb Company. Revenue in Genetic Obesity Drug Business (2017-2022) & (US$ Million)
Table 108. Bristol-Myers Squibb Company. Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genetic Obesity Drug Market Share by Drug Type: 2021 VS 2028
Figure 2. Sibutramine Features
Figure 3. Orlistat Features
Figure 4. Sympathomimetic Drugs Features
Figure 5. Receptors Antagonists Features
Figure 6. Others Features
Figure 7. Global Genetic Obesity Drug Market Share by Application in 2021 & 2028
Figure 8. Hospitals Pharmacy Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Online Pharmacy Case Studies
Figure 11. Others Case Studies
Figure 12. Genetic Obesity Drug Report Years Considered
Figure 13. Global Genetic Obesity Drug Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Genetic Obesity Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Genetic Obesity Drug Market Share by Region: 2021 VS 2028
Figure 16. Global Genetic Obesity Drug Market Share by Players in 2021
Figure 17. Global Top Genetic Obesity Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Obesity Drug as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Genetic Obesity Drug Revenue in 2021
Figure 19. North America Genetic Obesity Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. North America Genetic Obesity Drug Market Share by Country (2017-2028)
Figure 21. United States Genetic Obesity Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Genetic Obesity Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Genetic Obesity Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Genetic Obesity Drug Market Share by Country (2017-2028)
Figure 25. Germany Genetic Obesity Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Genetic Obesity Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Genetic Obesity Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Genetic Obesity Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Genetic Obesity Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Genetic Obesity Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Genetic Obesity Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Genetic Obesity Drug Market Share by Region (2017-2028)
Figure 33. China Genetic Obesity Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Japan Genetic Obesity Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. South Korea Genetic Obesity Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Southeast Asia Genetic Obesity Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. India Genetic Obesity Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Australia Genetic Obesity Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Genetic Obesity Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Genetic Obesity Drug Market Share by Country (2017-2028)
Figure 41. Mexico Genetic Obesity Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Brazil Genetic Obesity Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Genetic Obesity Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Genetic Obesity Drug Market Share by Country (2017-2028)
Figure 45. Turkey Genetic Obesity Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Saudi Arabia Genetic Obesity Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Pfizer, Inc. Revenue Growth Rate in Genetic Obesity Drug Business (2017-2022)
Figure 48. Sanofi. Revenue Growth Rate in Genetic Obesity Drug Business (2017-2022)
Figure 49. Tonghua Dongbao Pharmaceutical Co., Ltd. Revenue Growth Rate in Genetic Obesity Drug Business (2017-2022)
Figure 50. Biocon. Revenue Growth Rate in Genetic Obesity Drug Business (2017-2022)
Figure 51. Adocia Revenue Growth Rate in Genetic Obesity Drug Business (2017-2022)
Figure 52. GlaxoSmithKline Plc. Revenue Growth Rate in Genetic Obesity Drug Business (2017-2022)
Figure 53. Novo Nordisk A/S. Revenue Growth Rate in Genetic Obesity Drug Business (2017-2022)
Figure 54. Oramed Pharmaceuticals, Inc Revenue Growth Rate in Genetic Obesity Drug Business (2017-2022)
Figure 55. Wockhardt. Revenue Growth Rate in Genetic Obesity Drug Business (2017-2022)
Figure 56. Eli Lilly and Company. Revenue Growth Rate in Genetic Obesity Drug Business (2017-2022)
Figure 57. Merck & Co., Inc. Revenue Growth Rate in Genetic Obesity Drug Business (2017-2022)
Figure 58. Julphar. Revenue Growth Rate in Genetic Obesity Drug Business (2017-2022)
Figure 59. Bristol-Myers Squibb Company. Revenue Growth Rate in Genetic Obesity Drug Business (2017-2022)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Industry Market Size
